Genmab AS(GMAB)— 技术面状态
数据截至2026-11-02 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades +46.3% vs the 50-day and +79.4% vs the 200-day average, 8.4% below the 52-week high and +132.5% off the 52-week low; a golden cross printed 48 sessions ago. Computed from daily closes.
Ranked #20 on today’s Directional Flow — Rising fastest list (scan of 2026-11-02).
均线状态
- 相对20日均线+29.3%
- 相对50日均线+46.3%
- 相对200日均线+79.4%
- 52周区间低于52周高点8.4% · 高于52周低点132.5%
- 连续走势连续1个交易日下跌
- 均线交叉金叉(48个交易日前)
- 50日均线交叉股价向上穿越50日均线(87个交易日前)
- 随机指标%K 78.8 · %D 87.3
FAQ · from the current data · as of 2026-11-02
Quick answers
GMAB当前的Closelook信号是什么?
Uptrend stack intact — Trades +46.3% vs the 50-day and +79.4% vs the 200-day average, 8.4% below the 52-week high and +132.5% off the 52-week low; a golden cross printed 48 sessions ago. Computed from daily closes.(截至2026-11-02;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
GMAB目前是否位于50日和200日均线上方?
截至2026-11-02,Genmab AS位于50日均线上方(+46.3%),200日均线上方(+79.4%);距20日均线+29.3%。
GMAB距52周高点有多远?
截至2026-11-02,低于52周高点8.4%,高于52周低点132.5%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- EXEL Exelixis Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- VRDN Viridian Therapeutics Incindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- BHVN Biohaven Ltd.industry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- KYMR Kymera Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- IRON Disc Medicine Inc.industry